Complete Atrioventricular Septal Defects after the Age of 40 Years

Susanne J Maurer1, Lorena Moosholzer2, Claudia Pujol2

  • 1Department of Electrophysiology, German Heart Centre Munich, TUM School of Medicine, Technical University of Munich, 80636 Munich, Germany.

Insights

Older adults with complete atrioventricular septal defects (cAVSD) face significant health risks. New York Heart Association (NYHA) class predicts worse outcomes, highlighting the need for careful management in this growing population.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Adult Congenital Heart Disease

Background:

  • Increasing prevalence of adults with complete atrioventricular septal defects (cAVSD).
  • Limited data available on the outcomes of older adults diagnosed with cAVSD.
  • Growing population of adults with cAVSD necessitates understanding long-term health trajectories.

Purpose of the Study:

  • To analyze the clinical outcomes of adults aged 40 years and older with cAVSD.
  • To identify predictors of morbidity and mortality in this specific patient group.
  • To inform clinical management strategies for older adults with cAVSD.

Main Methods:

  • Retrospective analysis of patients with cAVSD aged ≥40 years between 2005 and 2018.
  • Data extraction from hospital records.
  • Primary endpoint defined as all-cause death or unplanned cardiac hospitalizations.

Main Results:

  • 43 patients (60.5% female, mean age 43.7 years) were included; 58.1% had genetic syndromes.
  • Most patients (95.3%) were in NYHA class I or II at baseline; 60.5% had prior cardiac surgery.
  • 93.0% had at least one extracardiac comorbidity; NYHA class predicted the primary endpoint (HR 1.96, p<0.05).

Conclusions:

  • Adults with cAVSD over 40 years experience significant morbidity and mortality.
  • New York Heart Association (NYHA) functional class is a key predictor of adverse outcomes.
  • Clinical monitoring and management should consider functional class in older cAVSD patients.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
88
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
48
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
54
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
94
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
79
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
84